Business
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab(TM) Platform
VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVC...
About this update from Avricore Health Inc.
[{"type":"text","content":"Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform\nVANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the \"Company\" or “Avricore”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada. Expansion Roadmap The Company has published “The Path Forward,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation is now available on the Company’s website at avricore.com/investor-kit. The update outlines Avricore’s progression from NHS-linked pilot programmes in London toward broader regional and national expansion across England, supported by clinical outcomes, independent evaluation, and growing institutional support. UK Programme Milestones HealthTab has gained meaningful traction within the NHS, including the screening of more than 3,500 patients in community pharmacies across North East and North Central London through a collaboration with Barts Health NHS Trust. In an initial lipid-screening cohort of 556 patients, approximately one in five was identified as having elevated cardiovascular risk. The programme has been independently evaluated by UCLPartners and has received attention from NHS England’s Chief Pharmaceutical Officer, as well as coverage by BBC National News. In addition, the British Heart Foundation, awarded a $385,000 grant to Barts Health, supporting an Inclisiran secondary-prevention pilot within the pharmacy network featuring HealthTab. Expanding Test Menu and Revenue Model HealthTab is continuing to expand its test menu within the NHS network. HbA1c testing for diabetes screening launched in Q1 2026, and UACR kidney function testing is planned for Q3 2026. In the first month of HbA1c availability, the network completed 2,295 tests in total across 57 pilot locations, approaching the ~3,000 tests per month average previously achieved across more than 700 locations in Canada. The Com...